The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial
Open accessPublished version of a preprint
Abstract
Background Probiotics have been proposed as adjuvants for Coronavirus Disease 2019 (Covid19) but randomized controlled trials (RCT) are lacking. Methods Single-center, quadruple-blinded RCT. Symptomatic Covid 19 outpatients (aged 18 to 60 years) with positive SARS-CoV2 nucleic acids test were randomized to active (n=150; ≥2×10 9 colony-forming units (CFU) of probiotic strains Lactiplantibacillus plantarum KABP022, KABP023 and KAPB033, plus strain Pediococcus acidilactici KABP021) or placebo (n=150), take orally once daily for 30 days. Oral acetaminophen was allowed and controlled as co-intervention. Primary endpoint included: i) proportion of patients in complete remission (both symptoms and nucleic acids test) or progressing to moderate or severe disease with hospitalization; ii) death rate and duration on Intensive Care Unit (ICU). Safety was assessed in all patients. This study is registered at ClinicalTrials.gov ( NCT04517422 ). Findings 300 subjects were randomized (median age 37.0 years [range 18 to 60], 161 [53.7%] women, 126 [42.0%] having known metabolic risk factors), and 293 completed the study (97.7%). Remission was achieved by 78 of 147 (53.1%) in the active group compared to 41 of 146 (28.1%) in placebo (P<0.0001; ARR=25.0% [95%CI 14.1-35.9%]), still significant after multiplicity correction for the primary endpoint. No hospitalizations or deaths occurred during the study, precluding the assessment of efficacy on these endpoints. No serious adverse events occurred during the study. Replication studies with this probiotic formula are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · cited 1×
“Of note, neutralizing antibodies were not measured, but recent research indicates immunoglobulins to spike antigens provide a good correlate to both neutralization(31,32) and efficacy,(33) and spike-specific memory B-cells have been found to persist for months after infection.(34,35) Our findings, together with the re…”
Gut biogeography of the bacterial microbiota
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro3552 · Cited by 2,535 · cited 1×
“This ecological succession is further influenced by the high disparity in bacterial densities between the small intestine (increasing from 10(4) to 10(8) cfu/mL) and the colon (10(11)–10(12) cfu/mL).(43,44) Accordingly, fecal microbiota is a proxy for the microbiota of the distal colon, but it becomes less and less re…”
BackgroundPopulation-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Wang, P., Nair, M. S., Liu, L., Iketani, S., Luo, Y., Guo, Y., Wang, M., Yu, J., Zhang, B., Kwong, P. D., et al. (2021) · Nature · doi:10.1038/s41586-021-03398-2 · Cited by 2,312
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
Weinreich, D. M., Sivapalasingam, S., Norton, T., Ali, S., Gao, H., Bhore, R., Musser, B. J., Soo, Y., Rofail, D., Im, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035002 · Cited by 1,642 · cited 2×
“Recent randomized trials in Covid19 outpatients also found a combined incidence of hospitalization plus emergency department visit of just 6% in placebo groups.(18,19,23) Our entry criteria (e.”
BackgroundResult
Research works printed but not linked: 43
- 10.1038/s41586-020-2488-1 · DOI · Paper page
- 10.1038/nrmicro.2016.142 · DOI · Paper page
- 10.1017/S0007114514000075 · DOI · Paper page
- 10.1111/j.1574-695X.2008.00413.x · DOI · Paper page
- 10.1186/1471-2180-10-293 · DOI · Paper page
- 10.1371/journal.pone.0010632 · DOI · Paper page
- Zhao W, Peng C, Sakandar HA, Kwok L-Y, Zhang W. Meta-analysis: randomized trials of Lactobacillus plantarum on immune regulation over the last decades. Front Immunol. 2021;12:728.
- 10.1080/19490976.2021.1900997 · DOI
- 10.3389/fnut.2021.669808 · DOI
- 10.3389/fnut.2020.613928 · DOI
- 10.1016/S1473-3099(20)30483-7 · DOI · Paper page
- 10.1001/jama.2021.0202 · DOI · Paper page
- 10.1001/jama.2021.3071 · DOI · Paper page
- 10.1016/S2213-2600(20)30566-X · DOI · Paper page
- 10.1038/s41467-020-20168-2 · doi:10.1038/s41467-020-20168-2
- 10.1001/jamanetworkopen.2021.6468 · DOI
- 10.1001/jamanetworkopen.2021.0369 · DOI · Paper page
- 10.1038/d41586-021-00650-7 · doi:10.1038/d41586-021-00650-7
- 10.1038/s41574-021-00495-0 · DOI
- 10.1016/j.ijid.2020.05.021 · DOI · Paper page
- 10.1016/j.jcv.2021.104879 · DOI
- 10.1038/s41467-021-22958-8 · DOI · Paper page
- 10.1080/2222175120211913973 · doi:10.1080/2222175120211913973
- 10.1016/j.vaccine.2021.05.063 · DOI · Paper page
- 10.1016/j.xcrm.2021.100290 · DOI · Paper page
- Martínez-Romero E, Aguirre-Noyola JL, Bustamante-Brito R, González-Román P, Hernández-Oaxaca D, Higareda-Alvear V, Montes-Carreto LM, Martínez-Romero JC, Rosenblueth M, Servín-Garcidueñas LE. We and herbivores eat endophytes. Microb Biotechnol. 2020;1–18.
- 10.1136/gutjnl-2020-323020 · DOI · Paper page
- 10.1038/s41564-018-0143-5 · DOI
- 10.1038/nmicrobiol.2016.93 · DOI · Paper page
- Kastl AJ, Terry NA, Wu GD, Albenberg LG. The structure and function of the human small intestinal microbiota. Curr Understanding Future Directions. 2020;9:33–45.
- 10.3389/fcimb.2019.00454 · DOI · Paper page
- 10.1038/s41385-021-00389-4 · DOI · Paper page
- 10.1080/19490976.2019.1707015 · DOI
- 10.1111/j.1365-2567.2010.03301.x · DOI
- 10.1038/s42003-021-02724-8 · DOI
- 10.1016/j.chom.2019.07.002 · DOI · Paper page
- 10.1038/s41577-020-00486-8 · DOI
- 10.1093/eurheartj/ehaa1103 · DOI · Paper page
- 10.1111/ijlh.13336 · DOI
- 10.15585/mmwr.mm6942e1 · DOI · Paper page
- 10.2807/1560-7917.ES.2020.25.3.2000045 · DOI · Paper page
- 10.1007/BF01535722 · DOI · Paper page
- 10.1128/AEM.02343-19 · DOI · Paper page
Cited by
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Maftei, N.-M., Raileanu, C. R., Balta, A. A., Ambrose, L., Boev, M., Marin, D. B., & Lisa, E. L. (2024) · Microorganisms · doi:10.3390/microorganisms12020234 · Cited by 381
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Zhang, F., Lau, R. I., Liu, Q., Su, Q., Chan, F. K. L., & Ng, S. C. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00698-4 · Cited by 267
Rizvi, S. A. A., Einstein, G. P., Tulp, O. L., Sainvil, F., & Branly, R. (2022) · Biomolecules · doi:10.3390/biom12101442 · Cited by 181
“The COVID-19 outpatients and early viral and symptomatic remission [144].”
BackgroundFrom Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · doi:10.20944/preprints202506.0880.v1 · Cited by 24
Metadata
- Authors
- Gutiérrez-Castrellón, P., Gandara-Martí, T., Abreu Y Abreu, A. T., Nieto-Rufino, C. D., López-Orduña, E., Jiménez-Escobar, I., Jiménez-Gutiérrez, C., López-Velazquez, G., & Espadaler-Mazo, J.
- Venue
- Gut Microbes
- Publisher
- Informa UK Limited
- Published
- 2022-01-11
- Volume
- 14
- Issue
- 1
- Pages
- 2018899-2018899
- ISSN
- 1949-0976 (ISSN-L)
- 1949-0984
- OpenAlex
- W4205246868
- Cited by
- 217
- References
- 25
- FWCI
- 23.35
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- doi.org/10.1080/policies-text-data-mining (tdm)
- Funders
- AB-Biotics SA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. https://app.cochat.ai/papers/10.1080/19490976.2021.2018899
- The paper
- Gutiérrez-Castrellón, P., Gandara-Martí, T., Abreu Y Abreu, A. T., Nieto-Rufino, C. D., López-Orduña, E., Jiménez-Escobar, I., Jiménez-Gutiérrez, C., López-Velazquez, G., & Espadaler-Mazo, J. (2022). Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes. https://doi.org/10.1080/19490976.2021.2018899
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.